Orexigen Therapeutics Inc (OTC Pink - No Information:OREXQ)

Delayed Data
As of Apr 20
 -0.0142 / -8.58%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 3.50, with a high estimate of 3.50 and a low estimate of 3.50. The median estimate represents a +2,220.95% increase from the last price of 0.15.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Sell stock in Orexigen Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Sell rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -5.34%
Growthannually 32.94%


Growthquarterly 10.00%
Growthannually 26.44%
Key to the earnings and sales forecast charts.